RESUMEN
Transgenic expression in the hypothalamus of syndecan-1, a cell surface heparan sulfate proteoglycan (HSPG) and modulator of ligand-receptor encounters, produces mice with hyperphagia and maturity-onset obesity resembling mice with reduced action of alpha melanocyte stimulating hormone (alphaMSH). Via their HS chains, syndecans potentiate the action of agouti-related protein and agouti signaling protein, endogenous inhibitors of alphaMSH. In wild-type mice, syndecan-3, the predominantly neural syndecan, is expressed in hypothalamic regions that control energy balance. Food deprivation increases hypothalamic syndecan-3 levels several-fold. Syndecan-3 null mice, otherwise apparently normal, respond to food deprivation with markedly reduced reflex hyperphagia. We propose that oscillation of hypothalamic syndecan-3 levels physiologically modulates feeding behavior.
Asunto(s)
Conducta Alimentaria/fisiología , Hipotálamo/fisiología , Glicoproteínas de Membrana/fisiología , Proteoglicanos/fisiología , Envejecimiento/fisiología , Secuencia de Aminoácidos , Animales , Glucemia/metabolismo , Corticosterona/sangre , Femenino , Factor 2 de Crecimiento de Fibroblastos/metabolismo , Privación de Alimentos , Humanos , Hiperfagia/genética , Hiperfagia/fisiopatología , Insulina/sangre , Leptina/sangre , Masculino , Glicoproteínas de Membrana/química , Glicoproteínas de Membrana/deficiencia , Glicoproteínas de Membrana/genética , Ratones , Ratones Noqueados , Ratones Transgénicos , Datos de Secuencia Molecular , Mutagénesis , Obesidad/genética , Obesidad/fisiopatología , Proteoglicanos/química , Proteoglicanos/deficiencia , Proteoglicanos/genética , Receptores de Factores de Crecimiento de Fibroblastos/fisiología , Sindecano-1 , Sindecano-3 , Sindecanos , alfa-MSH/metabolismoRESUMEN
Complementary molecular and genetic approaches are yielding information about gain- versus loss-of-function phenotypes of specific genes and gene families in the embryonic, fetal, neonatal, and adult lungs. New insights are being derived from the conservation of function between genes regulating branching morphogenesis of the respiratory organs in Drosophila and in the mammalian lung. The function of specific morphogenetic genes in the lung are now placed in context with pattern-forming functions in other, better understood morphogenetic fields such as the limb bud. Initiation of lung morphogenesis from the floor of the primitive foregut requires coordinated transcriptional activation and repression involving hepatocyte nuclear factor-3beta, Sonic hedgehog, patched, Gli2, and Gli3 as well as Nkx2.1. Subsequent inductive events require epithelial-mesenchymal interaction mediated by specific fibroblast growth factor ligand-receptor signaling as well as modulation by other peptide growth factors including epidermal growth factor, platelet-derived growth factor-A and transforming growth factor-beta and by extracellular matrix components. A scientific rationale for developing new therapeutic approaches to urgent questions of human pulmonary health such as bronchopulmonary dysplasia is beginning to emerge from work in this field.
Asunto(s)
Pulmón/embriología , Morfogénesis/genética , Transactivadores , Animales , Drosophila/crecimiento & desarrollo , Proteínas Hedgehog , Humanos , Proteínas Oncogénicas/genética , Proteínas/genética , Transducción de Señal , Tráquea/crecimiento & desarrollo , Factores de Transcripción/genética , Factores de Transcripción/fisiología , Proteína con Dedos de Zinc GLI1RESUMEN
Proliferation of smooth muscle cells from the pulmonary arteries and aortas of fetal calves is inhibited by heparin in vitro. This effect is reversible and dose dependent. Comparisons with effects of other polysaccharides indicate that only extensively sulfated polysaccharides inhibit proliferation of smooth muscle cells but that specific structural features of heparin are required to achieve maximum effect. Heparin-Sepharose chromatography of medium containing fetal calf serum reduces the ability of that medium to promote growth of smooth muscle cells from fetal pulmonary arteries, suggesting that heparin may remove soluble growth factors in serum. However, inhibition of fetal pulmonary artery smooth muscle cell proliferation by heparin is identical in media supplemented either with serum prepared from fetal calf plasma, in which platelet-derived growth factor (PDGF) is not detectable, or with fetal calf serum, which contains relatively abundant PDGF (114 pg/ml). Thus, inhibition of fetal pulmonary artery smooth muscle cell proliferation by heparin is not mediated solely by decreased availability or activity of exogenous PDGF. These studies suggest that morphogenesis of the smooth muscle investment of the pulmonary arteries could be regulated by local production of heparin-like inhibitors of smooth muscle cell growth.